TIGIT and cancer: In contrast to our findings, the functional performance of TIGIT+ NK cells was reported to be lower as compared to TIGIT−, although most of the studies examined NK cells derived from tumor-bearing mice or patients either with chronic infection or cancer, which were likely already exhausted [22,26,28,76].